Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis.
Giovannoni G, Knappertz V, Steinerman JR, Tansy AP, Li T, Krieger S, Uccelli A, Uitdehaag BMJ, Montalban X, Hartung HP, Pia Sormani M, Cree BAC, Lublin F, Barkhof F. Giovannoni G, et al. Among authors: barkhof f. Neurology. 2020 Aug 25;95(8):e1027-e1040. doi: 10.1212/WNL.0000000000010284. Epub 2020 Jul 10. Neurology. 2020. PMID: 32651286 Clinical Trial.
Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial.
van Oosten BW, Lai M, Hodgkinson S, Barkhof F, Miller DH, Moseley IF, Thompson AJ, Rudge P, McDougall A, McLeod JG, Adèr HJ, Polman CH. van Oosten BW, et al. Among authors: barkhof f. Neurology. 1997 Aug;49(2):351-7. doi: 10.1212/wnl.49.2.351. Neurology. 1997. PMID: 9270561 Clinical Trial.
Interleukin-2 therapy does not exacerbate multiple sclerosis.
van Oosten BW, Uitdehaag BM, Barkhof F, Hartung HP, Wagstaff J, Polman CH. van Oosten BW, et al. Among authors: barkhof f. Neurology. 1997 Aug;49(2):633-4. doi: 10.1212/wnl.49.2.633. Neurology. 1997. PMID: 9270618 No abstract available.
Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions.
van Waesberghe JH, Castelijns JA, Roser W, Silver N, Yousry T, Lycklama à Nijeholt GJ, Adèr HJ, Uitdehaag BM, Radue EW, Polman CH, Kappos L, Miller DH, Barkhof F. van Waesberghe JH, et al. Among authors: barkhof f. AJNR Am J Neuroradiol. 1997 Aug;18(7):1279-85. AJNR Am J Neuroradiol. 1997. PMID: 9282855 Free PMC article.
1,489 results